All Posts: cancer research
-
Months After Chemotherapy, MD/PhD Student Bikes 50 Miles for Cancer Research
A year and a half into medical school at Georgetown, Bryan Weselman was diagnosed with cancer. Now, he’s researching cancer to improve treatment for other patients.
Category: GUMC Stories
-
For This Medical Student, Her Cancer Research Is for Her Little Sister
Ritu Amarnani (M’27), a second-year medical student, spent this summer researching cancer care at Georgetown’s Lombardi Comprehensive Cancer Center. She turned her career focus toward medicine after her younger sister’s cancer diagnosis and death.
Category: GUMC Stories
-
Could a Georgetown Lab Finding Lead to New Treatment in Pancreatic Cancer?
For the first time, new research by Georgetown scientists shows potential to make immunotherapy effective in pancreatic cancer by combining it with a drug that makes cancer cells more responsive to immunotherapy.
Category: GUMC Stories
-
Understanding Immunotherapy Resistance Leads to New Therapeutic Strategies — and Hope
Samir Khleif, MD, an immunologist and professor of oncology at Georgetown Lombardi, is working to understand why some cancers become resistant to immunotherapy, and how that resistance can be overcome.
Category: GUMC Stories
-
Ruesch Center Symposium Focuses on Early-Onset GI Cancer
With an emphasis on early-onset gastrointestinal cancer, the 14th Annual Ruesch Center Symposium brought together nearly 300 health care providers, researchers, advocates, patients and caregivers November 16-18 to honor those dedicated to curing GI cancers, discuss the experiences of patients and caregivers, and share the latest research in the field.
Category: GUMC Stories
-
Lombardi Women Event Rallies Support for Breast Cancer Research
The 17th Annual Lombardi Women event brought together nearly 400 of the Washington area’s most influential women in support of Georgetown University’s Lombardi Comprehensive Cancer Center and its Nina Hyde Center for Breast Cancer Research.
Category: GUMC Stories
-
Biology Behind New Drug Used to Treat Triple-Negative Breast Cancer Uncovered
How TTP488 (azeliragon), an experimental drug, impairs aggressive, triple-negative breast cancer from metastasizing has been uncovered at the cellular level, according to researchers at Georgetown University’s Lombardi Comprehensive Cancer Center.
Category: News Release
-
Researchers Develop Method to Monitor Cancer Radiotherapy Effects at the Cellular Level
Using complex molecular tools, Georgetown Lombardi researchers have determined how to measure, in real time, the effect that radiation treatment for cancer can have at the cellular level on surrounding healthy tissue.
Category: News Release
-
Novel Research Shows Older Breast Cancer Survivors Experience Accelerated Aging, Worse Functional Outcomes
In a new multicenter study, researchers from Georgetown University’s Lombardi Comprehensive Cancer Center, the Medical College of Wisconsin (MCW), UCLA and several other leading cancer centers from across the nation examined whether cancer and its treatments accelerate aging.
Category: News Release
-
Determining How a Sugar Molecule Can Affect Cancer Cell Response to Chemoradiotherapy
Researchers at Georgetown University’s Lombardi Comprehensive Cancer Center and colleagues who have been exploring the complexities of biochemical pathways involved in cancer development have found that a form of glucose, a type of sugar, is intricately linked to a pathway used to build DNA molecules. When this pathway is overactive, it can lead to cancer and resistance to chemoradiotherapy.
Category: News Release